PHOSPHOENZYMQMMMProject reference: 622711
Funded under :
"Phosphate Processing in Enzymes: Structure, Dynamics and Chemistry"
Total cost:EUR 309 235,2
EU contribution:EUR 309 235,2
Coordinated in:United Kingdom
Topic(s):FP7-PEOPLE-2013-IEF - Marie-Curie Action: "Intra-European fellowships for career development"
Call for proposal:FP7-PEOPLE-2013-IEFSee other projects for this call
Funding scheme:MC-IEF - Intra-European Fellowships (IEF)
"Phosphate ester hydrolysis is one of the most important classes of chemical reactions in biology, playing a central role in nucleic acid processing, energy transduction, and signalling. Despite the importance of this ubiquitous reaction, the mechanistic details of phosphate ester cleavage remain obscure due to the complex nature of the reaction. In addition, there is an active debate concerning possible reaction intermediates. Here we aim to clarify the molecular basis of this enzymatic mechanism by studying P-O bond cleavage by Nucleoside Triphosphate (NTP) - processing enzymes and by the HIV-RT system. Hydrolysis of NTP represents a biochemical reaction essential in most processes of life: energy storage and transfer, replication of the genetic material, translation, regulation, etc. We will clarify the roles of metal ions in NTP enzymes and the ubiquitous arginine finger-type interaction occurring during the catalytic process. Phosphate hydrolysis is also catalysed by the HIV-RT enzyme. HIV-RT is a main drug target for AIDS disease. Unfortunately, current HIV drugs cannot cure the disease, forcing patients to remain on viral suppressant medications indefinitely. The major emerging problem with the current HIV viral drugs is the acquired drug resistance. To combat this problem, it is essential to design new drugs that target alternative functions and binding sites. More than half of the current HIV drugs target the HIV-RT reverse transcriptase function. Nevertheless, HIV-RT also carries out an RNase H function that is essential to viral replication. Here, we aim to obtain detailed information on the conformational flexibility and tautomerism of the inhibitors and to find the link between these properties and the potency and selectivity of the RNase function inhibitors. By exploring the flexibility of the inhibitors as well as mutations in the protein, we also aim to identify how drug resistant mutants may emerge as a result of drug therapies."
EU contribution: EUR 309 235,2
WC2R 2LS London